KIR3DL1 and myeloid leukemia: Another KIR/HLA class I ligand combination where the activating KIR3DS1 is expressed, but not its putative HLA-A/BBw4 ligand, KIR3DS1(+)/L(-), was found at a lower frequency in the myeloid leukemia group compared to the healthy individuals.